Anti-infective compositions for treating disordered tissue such as cold sores
OwnerB. Ron Johnsoninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment of disordered epithelial tissues such as cold sores and other complications resulting from disorders such as herpes, and the like. The invention relates to the use of an anti-infective and/or antimicrobial active agent in a carrier, with vigorous agitation of the disordered epithelial tissue for topical treatment thereof under such conditions sufficient to achieve clinically discernable improvement of the disordered epithelial tissue. The preferred anti-infective and/or antimicrobial active agent is an organohalide such as a quaternary ammonium compound, preferably benzalkonium chloride. The inventive method may be used also in connection with a preferred applicator configuration.
Claims51
A treatment composition for application to and penetration into disordered tissue, the treatment composition comprising:
- at least one anti-infective agent in a carrier,
- the anti-infective agent comprising an organohalide, and
- wherein the treatment composition is a liquid comprising a tissue penetrating component for penetrating skin in a rapid manner without rapidly diffusing beyond the skin.
A treatment composition for application to and penetration into disordered tissue, the treatment composition comprising:
- at least one anti-infective agent in a carrier, and wherein
- the anti-infective agent comprises at least one benzalkonium chloride compound,
- the carrier comprises isopropyl alcohol, and
- the treatment composition is a liquid comprising a tissue penetrating component for penetrating skin in a rapid manner without rapidly diffusing beyond the skin.
A treatment composition for application to and penetration into disordered tissue, the treatment composition comprising:
- at least one benzalkonium chloride compound in a carrier, and wherein
- the carrier is comprised of a mixture of isopropyl alcohol and water, and
- the treatment composition is a liquid comprising a tissue penetrating component for penetrating skin in a rapid manner without rapidly diffusing beyond the skin.
A treatment composition for application to and penetration into disordered tissue, the treatment composition comprising:
- at least one benzalkonium chloride compound in a carrier, and wherein
- the carrier is comprised of a mixture of isopropyl alcohol and water,
- the treatment composition is a liquid comprising a tissue penetrating component for penetrating skin in a rapid manner without rapidly diffusing beyond the skin, and the treatment composition is substantially oil free such that there is essentially no residue remaining that is visibly detectable to any substantial degree after the treatment composition has been applied and absorbed.
A treatment composition for application to and penetration into disordered tissue, the treatment composition comprising:
- at least one benzalkonium chloride compound in a carrier,
- and wherein the carrier is comprised of a mixture of isopropyl alcohol and water, the water being in the range from about 20% to about 40% by volume of the carrier, and
- the treatment composition is a liquid comprising a tissue penetrating component for penetrating skin in a rapid manner without rapidly diffusing beyond the skin.
A treatment composition for application to and penetration into disordered tissue, the treatment composition comprising:
- at least one benzalkonium chloride compound in a carrier, and wherein
- the carrier comprises an aqueous solution of isopropyl alcohol at a concentration of about 70% by volume of the carrier, and
- the treatment composition is a liquid comprising a tissue penetrating component for penetrating skin in a rapid manner without rapidly diffusing beyond the skin.
Dependencies are inferred from the claim text.